Looking Back, Looking Forward: New HFI Strategy Coming in 2023
In January, we look forward to sharing HFI’s updated strategy! Informed by partner conversations and our first four years of operation, the new strategy represents a pivot from our current approach. For more information, keep an eye out for our January newsletter.
Highlights from 2022
In this month’s newsletter, we’re sharing 12 of our highlights from 2022, as we reflect on the year. These are presented in chronological order starting with January 2022.
Thank you to all of our partners, funders, and supporters for making these achievements possible! We look forward to working with you in 2023 as we continue in our mission of closing the financing gap for NCDs.
1. HFI on the Virtual Davos Gender Equity Lounge stage
In January, HFI CEO Dr. Andrea Feigl moderated a panel of powerful and accomplished female executives at the Female Quotient’s Virtual Davos Equity Lounge. These leaders discussed changing the face of finance, the impact and opportunity they see during the pandemic, the importance of public-private partnerships in promoting better solutions and solidarity for global health, and the unique challenges for women.
2. HFI's 2022 Skoll World Ecosystem Event
In April, HFI hosted its first World Forum Event of 2022. We were honored to have a group of profound leaders join us in this event, sharing their views on defining post-pandemic global health solidarity. If you missed it, be sure to watch the recording!
In May, HFI CEO Dr. Andrea Feigl moderated a panel at an event hosted by The Female Quotient at the Equality Lounge @ Davos. The panel focused on international development and financial sector leadership on post-pandemic recovery and preparedness. The discussion included the pathway for equitably financing the pandemic recovery and overcoming systemic health and wealth equity barriers.
4. HFI’s Breakfast Event at the 75th World Health Assembly
HFI hosted a breakfast event at the 75th World Health Assembly, entitled “Global Health Financing: Creating Solidarity, Managing Sustainability, & Closing the Gap.” We were joined by remarkable health finance leaders that discussed pandemic and NCD financing impasses, potential innovative finance and blended finance pathways to achieve better finance, health, economic return on investment, and collaborative actions that the global health community can take to achieve SDG 3.
5. HFI Rallies with Others to Institute Change in Davos, Geneva, and Beyond
In May, HFI was represented in Geneva and Davos, Switzerland during the 75th World Health Assembly (WHA). As multiple events were held in these locations, HFI was a prominent player at the World Heart Summit (WHS) and World Economic Forum (WEF).
6. HFI CEO at the Launch of the Access to Oncology Medicines (ATOM) Coalition
The Access to Oncology Medicines (ATOM) Coalition aims to help low- and lower-middle-income countries access more essential cancer medicines. The Coalition launched on May 22 with HFI as a partner organization. HFI CEO Dr. Andrea Feigl spoke at the launch event.
7. Presentation at Sanofi Global Health Unit
In July, Dr. Feigl spoke at Sanofi’s Global Health Unit in Paris on Building Holistic and Resilient Health Systems to Manage Non-Communicable Diseases. Panelists conveyed the importance of unmet needs in healthcare and healthcare access for those with cardio metabolic conditions, diabetes, and cancer in LMICs. Dr. Feigl addressed how institutions and governments need to invest in chronic care systems to tackle supply chain barriers to NCD medicines and products and understand the pipeline of cash flow in public and private sectors.
8. Continuing to Combat Type 1 Diabetes in Mexico
Throughout the year, HFI continued collaborating with the leadership in Jalisco, Mexico, as well as other partners, to support the rollout of “La Salud Como un Derecho, y no un Privilegio" (Health as a Right, and not a Privilege). This initiative aims to provide education, access, and support for children living with Type 1 Diabetes. Children in these areas lack sustained access to appropriate insulin and related glucose measurement devices.
Jalisco State and HFI are leading the Devices for Development Consortium (D4DC), a global consortium bringing together the private and public sectors for a volume guarantee mechanism to improve access to glucose monitoring devices, medicines, education, and care.
9. Supporting the Vaccine Supply Chain in Kenya
HFI partnered with IPE Global on a United States Agency for an International Development (USAID) project to understand the challenges in the vaccine supply chain in Africa and assess opportunities for a financially viable and operationally practical blended finance facility. The HFI team visited Nairobi to gather data to develop a comprehensive roadmap for using blended finance instruments to support the COVID-19 vaccine supply chain in Kenya. The team also explored opportunities for public and private partnerships and investments to address the overall healthcare supply chain in Kenya.
10. HFI and Health Wildcatters Are Supporting Aptus.Life
HFI and Health Wildcatters are partnering to support Aptus.Life, a healthcare startup that was mutually selected by both organizations. Aptus.Life aims to improve health outcomes via the Aptus.Life platform of enhanced Remote Patient Monitoring and Chronic Care. The organization is incentivizing providers and persons with chronic disease to manage their conditions, driving the double bottom line of both better health and better economic outcomes.
11. HFI at Roche-Sponsored World Cancer Congress Event
Roche brought together global experts on health financing for a discussion of innovative funding models, trends, opportunities, and case studies. Dr. Andrea Feigl joined three other panelists to share information on implementing innovative financing approaches, challenges, and what can be learned in implementation processes. She included a discussion of how HFI plays a role in addressing cancer care, the financing gap in LMICs, and investment models.
12. HFI at the United Nations General Assembly
HFI participated in a week full of activities at the United Nations General Assembly (UNGA 77). Throughout the week, we built on existing partnerships and fostered new ones with policymakers and stakeholders who have made unwavering commitments to fighting NCDs by 2030. HFI had representation at different events hosted throughout the week from four individuals:
CEO of HFI, Dr. Andrea Feigl
Global Health Economics Consultant, Tia Livingston
Technical Advisor, Geoffrey So
Senior Advisor, Kyle Peterson
Careers at HFI
We continue to seek candidates for our senior role of Health Economics Lead. Please share with your networks!
This role will lead client-facing health economics projects and will be a key contributor to HFI’s work.
We are also continuing to recruit for a Senior Global Health Finance Associate and Senior Health Economics Advisor. All of these roles can be found on the Careers page of our website.
